Dr Reddy’s trades in green on the BSE

17 Jul 2012 Evaluate

Dr Reddy is currently trading at Rs. 1712.95, up by 37.45 points or 2.24% from its previous closing of Rs. 1675.50 on the BSE.

The scrip opened at Rs. 1690.00 and has touched a high and low of Rs. 1717.35 and Rs. 1690.00 respectively. So far 24,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1818.00 on 20-Apr-2012 and a 52 week low of Rs. 1387.00 on 22-Aug-2011.

Last one week high and low of the scrip stood at Rs. 1,717.35 and Rs. 1636.05 respectively. The current market cap of the company is Rs. 29,063 crore.

The promoters holding in the company stood at 25.57% while Institutions and Non-Institutions held 40.32% and 17.32% respectively.

Dr Reddy’s Laboratories, country’s pharma major has decided to introduce its biosimilars in developed markets. biosimilars are used to treat patients suffering from cancer at a price that is significantly more affordable than the corresponding innovator drugs. During 2011-12, the company’s global biosimilars business earned $26 million revenue reporting 25% year-on-year growth.

Recently, the company entered into a partnership with Merck Serono, a division of Germany-based Merck KGaA, to co-develop biosimilar compounds. The collaboration was to concentrate on monoclonal antibodies (MAbs) in the oncology segment besides, manufacturing and commercialization of the compounds.   

Dr. Reddys Lab Share Price

1266.60 0.65 (0.05%)
31-Dec-2025 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.95
Dr. Reddys Lab 1266.60
Cipla 1500.25
Zydus Lifesciences 912.60
Lupin 2098.55
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×